WO2005092327A1 - 歯根膜保護剤 - Google Patents
歯根膜保護剤 Download PDFInfo
- Publication number
- WO2005092327A1 WO2005092327A1 PCT/JP2005/003166 JP2005003166W WO2005092327A1 WO 2005092327 A1 WO2005092327 A1 WO 2005092327A1 JP 2005003166 W JP2005003166 W JP 2005003166W WO 2005092327 A1 WO2005092327 A1 WO 2005092327A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- periodontal
- periodontal ligament
- ligament
- protecting agent
- protective agent
- Prior art date
Links
- 230000003239 periodontal effect Effects 0.000 title claims abstract description 29
- 239000003223 protective agent Substances 0.000 title claims abstract description 22
- 210000002379 periodontal ligament Anatomy 0.000 claims abstract description 48
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 230000006378 damage Effects 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 16
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 235000008694 Humulus lupulus Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 241000605862 Porphyromonas gingivalis Species 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 239000000463 material Substances 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 26
- 230000001681 protective effect Effects 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000003814 drug Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 208000028169 periodontal disease Diseases 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000220225 Malus Species 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- 230000001172 regenerating effect Effects 0.000 description 8
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229940030275 epigallocatechin gallate Drugs 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 6
- 208000008312 Tooth Loss Diseases 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000021016 apples Nutrition 0.000 description 4
- 235000013736 caramel Nutrition 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 239000000551 dentifrice Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000014510 cooky Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108091020100 Gingipain Cysteine Endopeptidases Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 208000005888 Periodontal Pocket Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000004357 third molar Anatomy 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 241000605894 Porphyromonas Species 0.000 description 1
- 229930182622 Rubrin Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Definitions
- the present invention is derived from a proanthocyanin-like polyphenol having an effect of reducing the harmfulness of Porphyromonas ginrivalis to periodontal ligament, which is one of periodontal tissues, particularly preferably hop bract or apple immature fruit
- the present invention relates to a periodontal protective agent which is polyphenol and its use.
- Periodontal disease so-called periodontal disease, is a prevalent oral disease worldwide and is one of the leading causes of tooth loss. It is almost concluded that periodontal disease is an infection caused by bacteria, caused by plaque in periodontal pockets It is thought to be a variety of fungi, of which Porphyromonas gingivalis is thought to be the major causative organism.
- P. rinrivalis is a bacterium that is frequently detected in periodontal pockets of patients with periodontal disease and produces proteolytic enzymes (Arg-gingipain and Lys-gingipain) and LPS (lipopolysaccharide) with strong inflammatory properties. 'It is believed that the release causes destruction of periodontal tissues (periodontal ligament, alveolar bone). As a result, periodontal tissue cannot support the teeth, leading to tooth loss.
- the periodontal ligament is a tissue mainly composed of collagen fibers, and one side of the fibers is buried in the alveolar bone and the other side is buried in cementum.
- the periodontal ligament is an important tissue that has the function of bonding the tooth and the alveolar bone, and acts to absorb the force applied to the tooth and not directly apply the force to the bone.
- one of the most important processes in the development of periodontal disease is the destruction of the periodontal ligament and alveolar bone. Without these tissues, the teeth cannot withstand the forces needed for feeding.
- Techniques for preventing and improving periodontal disease include daily removal of physical plaque such as tooth brushing by individuals, polyphenols derived from green tea (Patent Document 1), and wood-derived techniques And the like (Patent Document 2). These anti-periodontal disease effect, inhibitory effect of proteolytic enzymes P. Ringivalis, or! 3, by inhibiting the adhesion of gingivalis into the cultured cells, its arresting the development of periodontal disease, a progressive It is the basis.
- Patent Document 1 JP-A-5-944
- Patent Document 2 JP-A-8-81380
- the inventors of the present invention have conducted intensive studies on the above-mentioned problems, and as a result, have found that the protosiadin-like polyphenol phenol P. gingivalis bacterium derived from hop bracts or immature apples has a strong effect on the periodontal ligament. It was found to have an inhibitory and protective effect. Also, the polyphenols are also confirmed to have an effect also reduces failures ⁇ ⁇ £ ⁇ 3 ⁇ 4 bacteria on regenerating induced periodontal membrane. Further, the present invention has been completed by using this substance as a periodontal ligament protective material in medicines, quasi-drugs such as mouth washes, and foods and drinks.
- polyphenol as used herein is a generic term for a compound mainly containing a plurality of phenolic hydroxyl groups in a molecule contained in a plant, and a proanthocyanin-like polyphenol is a red-based compound due to decomposition of caro-water.
- Compounds that produce the dye anthocyanin (Cyanidin or Delphi-Gin or Pelargodin)! , U.
- the first of the present invention relates to a periodontal protective agent which is a proanthocyanin-like polyphenol
- the second relates to a periodontal protective agent which is a proanthocyanin-like polyphenol derived from immature apples.
- it relates to a periodontal protective agent which is a proanthocyan-like polyphenol derived from hop bracts.
- Periodontal ligament As mentioned above, in the progression of periodontal disease (deterioration of the condition), one of the most important processes is the destruction of the periodontal ligament, and in order to solve the problem of tooth loss due to periodontal disease, Periodontal ligament There is a need for technology that protects computers. Also, in the field of regenerative medicine in the oral field, it is believed that the formation of regenerative teeth is in sight. Cannot be established. Therefore, there is a need for a technique for protecting the periodontal ligament even after losing teeth. ADVANTAGE OF THE INVENTION According to the present invention, it has an effect of strongly inhibiting and protecting the damage to the periodontal ligament caused by P. gingivalis bacteria, and is used as a periodontal protective material for drugs, quasi-drugs such as mouthwashes, and food and drink. Can be used.
- FIG. 1 is a graph showing the protective effect on periodontal ligament cells in Example 12.
- the vertical axis indicates absorbance.
- FIG. 2 is a graph showing the protective effect on periodontal ligament cells in Example 13.
- the vertical axis indicates periodontal regeneration rate (%), and the horizontal axis indicates time (h).
- the unripe apple fruit as a raw material of the present invention refers to a fruit that has been artificially removed before the apple fruit has matured, or a fruit that has fallen naturally from the apple fruit tree due to falling or the like.
- the hop bract which is a raw material of the present invention, is obtained by removing the rubulin portion from hop cones.
- hop bracts are obtained by pulverizing hop cones and removing the rubrin portion by sieving.
- hop bracts are useful for beer brewing, and the hop cones are formed directly into pellets without removing the hop bracts. There is a tendency to use it as pellets for beer brewing. Therefore, the raw material of the present invention is not particularly limited as long as it contains hop bracts, and there is no problem even if hop cones or hop pellets containing hop bracts are used as raw materials.
- the obtained periodontal ligament protective material is confectionery, foods, foods and drinks such as beverages, particularly preferably candy, chocolate, caramel, chewing gum, etc., relatively long oral residence time It can be used for food and drink. It can also be used by adding it to oral preparations such as gargles and dentifrices. When adding a periodontal ligament protective material to these foods and drinks and oral agents
- the periodontal protective material may be added as powder, but preferably, the periodontal protective material is a 12% aqueous solution or an aqueous alcohol solution or an alcohol solution, and the final concentration of the food or drink or oral agent is adjusted. Should be added so as to be 1 to 5000 ppm, preferably 100 to 2000 ppm.
- hop bracts 50 g of hop bracts were extracted with 1, OOOml of 40% ethanol aqueous solution at 50 ° C for 60 minutes with stirring. After filtration, the filtrate was concentrated under reduced pressure to a volume of 500 ml, and the concentrated solution was passed through a column filled with 150 ml of styrene divinylbenzene resin (Sepabeads SP70, manufactured by Mitsubishi Iridaku Co., Ltd.), and then washed with 500 ml of water. .
- Example 4 5 g of a periodontal ligament protective material obtained in the same manner as in Example 2 was dissolved in 500 ml of a 50% aqueous ethanol solution, and treated with an ultrafiltration membrane having a molecular weight cut off of 10,000. The remaining solution that had not passed through this membrane was concentrated and freeze-dried to obtain 2.2 g of a further purified periodontal ligament protection material as a yellow-brown powder.
- Example 4 5 g of a periodontal ligament protective material obtained in the same manner as in Example 2 was dissolved in 500 ml of a 50% aqueous ethanol solution, and treated with an ultrafiltration membrane having a molecular weight cut off of 10,000. The remaining solution that had not passed through this membrane was concentrated and freeze-dried to obtain 2.2 g of a further purified periodontal ligament protection material as a yellow-brown powder.
- Example 4 5 g of a periodontal ligament protective material obtained in the same manner as in Example 2 was dissolved in 500 ml of a 50% aque
- a dentifrice was prepared according to a conventional method. Note that, instead of the material obtained in Example 1, dentifrices to which the materials obtained in Examples 2 and 3 were respectively added were obtained in the same manner.
- a total of 100.0 parts by weight of each of the above components was used as a lozenge according to a conventional method.
- a troche prepared by adding the raw materials obtained in Examples 2 and 3 was obtained in the same manner.
- Example 1 Using a total of 100.0 parts by weight of each component described above, a chewing gum was prepared according to a conventional method. Note that chewing gum to which Examples 2 and 3 were added instead of Example 1 was also obtained.
- each component was made into a cookie according to a conventional method. Note that, instead of the material obtained in Example 1, cookies to which the materials obtained in Examples 2 and 3 were added were obtained in the same manner.
- Example 11
- Example 12 (Protective effect on periodontal ligament cells):
- Periodontal ligament cells were extracted from human periodontal ligament exfoliated from the central part of the root of the extracted human third molar, and cultured for 5-7 passages in DMEM medium, after confirming alkaline phosphatase activity.
- Epigallocatechin gallate derived from green tea was used as a comparative example as a polyphenol, and the periodontal ligament protective agents obtained in Examples 2 and 3 were used.
- the cells were washed three times with PBS and treated with a 25% aqueous solution of dataraldehyde for 5 minutes to fix the cells.
- the fixed cells were further washed three times with PBS, and the cells were stained with 0.5% crystal violet in a 20% methanol solution.
- the cells were further washed five times with PBS, and the absorbance at 590 nm was measured with a plate reader (BIO-Rad model 680).
- Periodontal ligament cells cells derived from periodontal ligament exfoliated from the central part of the extracted human third molar were cultured for 5-7 passages in DMEM medium, and Alphos activity was confirmed.
- Epigallocatechin gallate derived from green tea was used as a comparative example as a polyphenol, and the periodontal protective agent obtained in Examples 2 and 3 was used.
- P. rinrivalis used ATCC33277 strain.
- Emdgain registered trademark, EMD was used as a periodontal regeneration inducer.
- the membrane was scratched with a sharp needle tip, and epigallocatechin gallate (comparative example), Examples 1, 2 and 3 were added to the medium, and P. rinrivalis at 100 times the number of cells was further roasted.
- epigallocatechin gallate comparative example
- Examples 1, 2 and 3 were added to the medium, and P. rinrivalis at 100 times the number of cells was further roasted.
- FIG. 2 shows the test results. Examples 1, 2 and 3 (10 gZml each) were compared with a control (no polyphenol added, EMD + Pg) and 10 / zg / ml epigallocatechin gallate (Comparative Example: EGCg). The regeneration of the periodontal ligament was clearly seen.
- the protective agent for periodontal ligament according to the present invention has a protective effect on periodontal tissue in the field of regenerative medicine, and can be used for quasi-drugs such as medicines, mouthwashes, and foods and beverages.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Non-Alcoholic Beverages (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002520166A CA2520166A1 (en) | 2004-03-26 | 2005-02-25 | A protectant of periodontal membranes |
US10/545,412 US20060165609A1 (en) | 2004-03-26 | 2005-02-25 | Periodontal ligament-protecting agent |
JP2006511407A JPWO2005092327A1 (ja) | 2004-03-26 | 2005-02-25 | 歯根膜保護剤 |
EP05710716A EP1728509A4 (en) | 2004-03-26 | 2005-02-25 | MEANS OF PROTECTION OF THE PERIODONTAL LIGAMENT |
US11/640,301 US20070092456A1 (en) | 2004-03-26 | 2006-12-18 | Protectant of periodontal membranes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-091098 | 2004-03-26 | ||
JP2004091098 | 2004-03-26 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/640,301 Continuation US20070092456A1 (en) | 2004-03-26 | 2006-12-18 | Protectant of periodontal membranes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005092327A1 true WO2005092327A1 (ja) | 2005-10-06 |
Family
ID=35055972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/003166 WO2005092327A1 (ja) | 2004-03-26 | 2005-02-25 | 歯根膜保護剤 |
Country Status (9)
Country | Link |
---|---|
US (2) | US20060165609A1 (ja) |
EP (1) | EP1728509A4 (ja) |
JP (1) | JPWO2005092327A1 (ja) |
KR (2) | KR100821694B1 (ja) |
CN (1) | CN1764448A (ja) |
AU (1) | AU2005203558A1 (ja) |
CA (1) | CA2520166A1 (ja) |
TW (1) | TW200531699A (ja) |
WO (1) | WO2005092327A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007020830A1 (ja) * | 2005-08-18 | 2007-02-22 | Asahi Breweries, Ltd. | 口腔用組成物 |
EP2059136A1 (en) * | 2006-08-09 | 2009-05-20 | Coressence Limited | Apples with high polyphenolic content |
JP2011510093A (ja) * | 2008-02-08 | 2011-03-31 | コルゲート・パーモリブ・カンパニー | 口腔ケア製品ならびにその使用および製造の方法[0001]この出願は2008年2月8日に出願された米国一連番号61/027,427の利益を主張し、その内容を本明細書に援用する。 |
WO2014104064A1 (ja) | 2012-12-26 | 2014-07-03 | 株式会社エーゼット | 創傷治癒促進剤 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7038733B2 (en) | 2002-01-30 | 2006-05-02 | Ericsson Inc. | Television receivers and methods for processing signal sample streams synchronously with line/frame patterns |
WO2007146841A2 (en) * | 2006-06-09 | 2007-12-21 | The Board Of Trustees Of The University Of Illinois | Collagen cross-linking agents on dental restorative treatment and preventive dentistry |
KR102118102B1 (ko) * | 2018-06-21 | 2020-06-02 | 동의대학교 산학협력단 | 치주질환 예방 및 개선용 조성물 |
EP4037779A1 (en) | 2019-09-30 | 2022-08-10 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and metal ion |
WO2021062607A1 (en) | 2019-09-30 | 2021-04-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0477424A (ja) * | 1990-07-18 | 1992-03-11 | Lotte Co Ltd | 抗歯周病剤 |
JPH0631208B2 (ja) * | 1987-04-27 | 1994-04-27 | キッコーマン株式会社 | プロアントシアニジンの製造法 |
JPH07285876A (ja) * | 1993-12-06 | 1995-10-31 | Nikka Uisukii Kk | 果実ポリフェノールとその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH0881380A (ja) * | 1994-09-09 | 1996-03-26 | Suntory Ltd | 高分子量ポリフェノールを有効成分として含有する抗歯周病剤並びに抗歯周病性食品 |
JPH08104628A (ja) * | 1994-10-04 | 1996-04-23 | Sumitomo Pharmaceut Co Ltd | マトリックスメタロプロテアーゼ阻害剤 |
JPH08259453A (ja) * | 1993-12-06 | 1996-10-08 | Nikka Uisukii Kk | 果実ポリフェノール含有果汁とその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH08319433A (ja) * | 1995-05-29 | 1996-12-03 | Nikka Uisukii Kk | リンゴ赤色色素とその製造方法、酸化防止剤、血圧降下剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH09295944A (ja) * | 1996-03-06 | 1997-11-18 | Asahi Breweries Ltd | 抗う蝕性素材、その製造方法および用途 |
JPH11501918A (ja) * | 1995-03-09 | 1999-02-16 | ザ、プロクター、エンド、ギャンブル、カンパニー | 口腔組成物 |
WO1999044574A1 (en) * | 1998-03-06 | 1999-09-10 | Life Plus International | Toothpaste and mouth rinse compositions |
WO1999044440A1 (fr) * | 1998-03-04 | 1999-09-10 | Sunstar Inc. | Compositions alimentaires pour prevenir la parodontose ou la progression de la parodontose et methode de prevention et de traitement de la parodontose |
JPH11302142A (ja) * | 1998-04-24 | 1999-11-02 | Sunstar Inc | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
WO2001032131A1 (fr) * | 1999-10-29 | 2001-05-10 | Kyowa Hakko Kogyo Co., Ltd. | Agents d'amelioration de texture de la peau |
JP2001511153A (ja) * | 1997-02-04 | 2001-08-07 | ブイ. コスバブ,ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
JP2001275604A (ja) * | 2000-04-04 | 2001-10-09 | Kikkoman Corp | 果汁粉末組成物及びその製造方法、並びに該果汁粉末組成物を含有させてなる健康食品 |
JP2002029953A (ja) * | 2000-07-19 | 2002-01-29 | Sunstar Inc | 歯周病の予防または治療用の食品組成物、口腔用組成物 |
JP2002121133A (ja) * | 2000-10-13 | 2002-04-23 | Sunstar Inc | 歯周病予防用口腔内溶解錠 |
WO2002078726A1 (fr) * | 2001-03-28 | 2002-10-10 | Asahi Breweries,Ltd. | Neutralisant de proteotoxines |
JP2003504402A (ja) * | 1999-07-16 | 2003-02-04 | エルジー ハウスホールド アンド ヘルス ケア エルティーディー. | マトリックスメタロプロテアーゼを阻害するプロシアニジンオリゴマー及びこれを有効成分とする薬剤 |
JP2003252745A (ja) * | 2002-02-28 | 2003-09-10 | Shiseido Co Ltd | マトリックスメタロプロテアーゼ(MMPs)阻害剤 |
JP2003535111A (ja) * | 2000-06-09 | 2003-11-25 | マーズ インコーポレイテッド | ココアプロシアニジンを抽出する改良方法 |
WO2003099304A1 (fr) * | 2002-05-27 | 2003-12-04 | Morinaga & Co., Ltd. | Composition contre des bacteries parodontales, ainsi qu'aliments, boissons et eaux dentaires contenant cette composition contre des bacteries parodontales |
JP2004051513A (ja) * | 2002-07-18 | 2004-02-19 | Asahi Breweries Ltd | 抗腫瘍剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2128293C (en) * | 1993-12-06 | 2002-09-03 | Masayuki Tanabe | Fruit polyphenols and medicinal compositions containing them |
KR100773647B1 (ko) * | 1996-04-02 | 2008-11-07 | 마아스 인코포레이티드 | 코코아추출화합물과그제조방법및사용방법 |
US5948388A (en) * | 1998-06-12 | 1999-09-07 | Soft Gel Technologies, Inc. | Chewable softgel oral hygiene product |
US20030211183A1 (en) * | 1999-10-29 | 2003-11-13 | Kyowa Hakko Kogyo Co., Ltd. | Skin-improving agent |
JP4574788B2 (ja) * | 2000-03-24 | 2010-11-04 | 協和発酵バイオ株式会社 | プロアントシアニジン含有組成物 |
EP1281985A1 (de) * | 2001-07-30 | 2003-02-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren und Vorrichtung zur Wiedergabe von Festkörperschwingungen zur Vorhersage von Bruchvorgängen in Festkörpern, insbesondere in der Erdkruste |
-
2005
- 2005-02-25 KR KR1020057014687A patent/KR100821694B1/ko not_active IP Right Cessation
- 2005-02-25 JP JP2006511407A patent/JPWO2005092327A1/ja active Pending
- 2005-02-25 TW TW094105807A patent/TW200531699A/zh unknown
- 2005-02-25 WO PCT/JP2005/003166 patent/WO2005092327A1/ja not_active Application Discontinuation
- 2005-02-25 CA CA002520166A patent/CA2520166A1/en not_active Abandoned
- 2005-02-25 EP EP05710716A patent/EP1728509A4/en not_active Withdrawn
- 2005-02-25 AU AU2005203558A patent/AU2005203558A1/en not_active Abandoned
- 2005-02-25 CN CNA2005800000528A patent/CN1764448A/zh active Pending
- 2005-02-25 US US10/545,412 patent/US20060165609A1/en not_active Abandoned
- 2005-02-25 KR KR1020077018773A patent/KR20070097581A/ko not_active Application Discontinuation
-
2006
- 2006-12-18 US US11/640,301 patent/US20070092456A1/en not_active Abandoned
Patent Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0631208B2 (ja) * | 1987-04-27 | 1994-04-27 | キッコーマン株式会社 | プロアントシアニジンの製造法 |
JPH0477424A (ja) * | 1990-07-18 | 1992-03-11 | Lotte Co Ltd | 抗歯周病剤 |
JPH07285876A (ja) * | 1993-12-06 | 1995-10-31 | Nikka Uisukii Kk | 果実ポリフェノールとその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH08259453A (ja) * | 1993-12-06 | 1996-10-08 | Nikka Uisukii Kk | 果実ポリフェノール含有果汁とその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH0881380A (ja) * | 1994-09-09 | 1996-03-26 | Suntory Ltd | 高分子量ポリフェノールを有効成分として含有する抗歯周病剤並びに抗歯周病性食品 |
JPH08104628A (ja) * | 1994-10-04 | 1996-04-23 | Sumitomo Pharmaceut Co Ltd | マトリックスメタロプロテアーゼ阻害剤 |
JPH11501918A (ja) * | 1995-03-09 | 1999-02-16 | ザ、プロクター、エンド、ギャンブル、カンパニー | 口腔組成物 |
JPH08319433A (ja) * | 1995-05-29 | 1996-12-03 | Nikka Uisukii Kk | リンゴ赤色色素とその製造方法、酸化防止剤、血圧降下剤、アレルギー抑制剤、抗う蝕剤及び消臭剤 |
JPH09295944A (ja) * | 1996-03-06 | 1997-11-18 | Asahi Breweries Ltd | 抗う蝕性素材、その製造方法および用途 |
JP2001511153A (ja) * | 1997-02-04 | 2001-08-07 | ブイ. コスバブ,ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
WO1999044440A1 (fr) * | 1998-03-04 | 1999-09-10 | Sunstar Inc. | Compositions alimentaires pour prevenir la parodontose ou la progression de la parodontose et methode de prevention et de traitement de la parodontose |
WO1999044574A1 (en) * | 1998-03-06 | 1999-09-10 | Life Plus International | Toothpaste and mouth rinse compositions |
JPH11302142A (ja) * | 1998-04-24 | 1999-11-02 | Sunstar Inc | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
JP2003504402A (ja) * | 1999-07-16 | 2003-02-04 | エルジー ハウスホールド アンド ヘルス ケア エルティーディー. | マトリックスメタロプロテアーゼを阻害するプロシアニジンオリゴマー及びこれを有効成分とする薬剤 |
WO2001032131A1 (fr) * | 1999-10-29 | 2001-05-10 | Kyowa Hakko Kogyo Co., Ltd. | Agents d'amelioration de texture de la peau |
JP2001275604A (ja) * | 2000-04-04 | 2001-10-09 | Kikkoman Corp | 果汁粉末組成物及びその製造方法、並びに該果汁粉末組成物を含有させてなる健康食品 |
JP2003535111A (ja) * | 2000-06-09 | 2003-11-25 | マーズ インコーポレイテッド | ココアプロシアニジンを抽出する改良方法 |
JP2002029953A (ja) * | 2000-07-19 | 2002-01-29 | Sunstar Inc | 歯周病の予防または治療用の食品組成物、口腔用組成物 |
JP2002121133A (ja) * | 2000-10-13 | 2002-04-23 | Sunstar Inc | 歯周病予防用口腔内溶解錠 |
WO2002078726A1 (fr) * | 2001-03-28 | 2002-10-10 | Asahi Breweries,Ltd. | Neutralisant de proteotoxines |
JP2003252745A (ja) * | 2002-02-28 | 2003-09-10 | Shiseido Co Ltd | マトリックスメタロプロテアーゼ(MMPs)阻害剤 |
WO2003099304A1 (fr) * | 2002-05-27 | 2003-12-04 | Morinaga & Co., Ltd. | Composition contre des bacteries parodontales, ainsi qu'aliments, boissons et eaux dentaires contenant cette composition contre des bacteries parodontales |
JP2004051513A (ja) * | 2002-07-18 | 2004-02-19 | Asahi Breweries Ltd | 抗腫瘍剤 |
Non-Patent Citations (2)
Title |
---|
See also references of EP1728509A4 * |
SONG S-E. ET AL: "Inhibitory effect of procyanidin oligomer from elm cortex on the matrix metalloproteinases and proteases of periodontopathogens", JOURNAL OF PERIODONTAL RESEARCH, vol. 38, no. 3, June 2003 (2003-06-01), pages 282 - 289, XP002987940 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007020830A1 (ja) * | 2005-08-18 | 2007-02-22 | Asahi Breweries, Ltd. | 口腔用組成物 |
EP2059136A1 (en) * | 2006-08-09 | 2009-05-20 | Coressence Limited | Apples with high polyphenolic content |
JP2011510093A (ja) * | 2008-02-08 | 2011-03-31 | コルゲート・パーモリブ・カンパニー | 口腔ケア製品ならびにその使用および製造の方法[0001]この出願は2008年2月8日に出願された米国一連番号61/027,427の利益を主張し、その内容を本明細書に援用する。 |
WO2014104064A1 (ja) | 2012-12-26 | 2014-07-03 | 株式会社エーゼット | 創傷治癒促進剤 |
US9962364B2 (en) | 2012-12-26 | 2018-05-08 | A-Z Ltd. | Wound healing accelerator |
Also Published As
Publication number | Publication date |
---|---|
CA2520166A1 (en) | 2005-10-06 |
TW200531699A (en) | 2005-10-01 |
KR20060034624A (ko) | 2006-04-24 |
KR100821694B1 (ko) | 2008-04-11 |
US20060165609A1 (en) | 2006-07-27 |
JPWO2005092327A1 (ja) | 2008-02-07 |
US20070092456A1 (en) | 2007-04-26 |
AU2005203558A1 (en) | 2005-10-13 |
CN1764448A (zh) | 2006-04-26 |
EP1728509A4 (en) | 2010-03-17 |
EP1728509A1 (en) | 2006-12-06 |
KR20070097581A (ko) | 2007-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005092327A1 (ja) | 歯根膜保護剤 | |
US20110059193A1 (en) | Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats | |
KR102133638B1 (ko) | 산청목 추출물 및 계피 추출물을 포함하는 구강질환의 예방 또는 치료용 조성물 | |
WO2004026273A1 (ja) | 口腔用組成物 | |
WO2007020830A1 (ja) | 口腔用組成物 | |
KR100810946B1 (ko) | 법랑질의 탈석회화 억제물질 | |
JP2009263332A (ja) | オリーブ葉抽出物を含有する歯周組織健康維持剤 | |
JPH0881380A (ja) | 高分子量ポリフェノールを有効成分として含有する抗歯周病剤並びに抗歯周病性食品 | |
US20060251760A1 (en) | Process for producing hop glume polyphenol | |
JP5294536B2 (ja) | 歯肉上皮細胞伸展阻害剤 | |
KR102269164B1 (ko) | 녹두 씨앗 추출물 등을 이용한 치아우식증 및 치주질환 개선용 조성물 | |
JP2005035907A (ja) | 抗歯周病剤 | |
KR102063388B1 (ko) | 산청목 추출물 및 당귀 추출물을 포함하는 구강질환의 예방 또는 치료용 조성물 | |
JP4633399B2 (ja) | グルコシルトランスフェラーゼ阻害剤 | |
JP2005089374A (ja) | 血糖値上昇抑制機能性飲食品 | |
JP2003238426A (ja) | コラゲナーゼ阻害剤、皮膚外用剤および健康食品 | |
EP2057993A1 (en) | Method for production of hop preparation, hop preparation, antiinflammatory agent, food/beverage, and oral product | |
KR101814065B1 (ko) | 멜라닌 분해 촉진용 조성물 | |
JP2015071623A (ja) | オレウロペインおよびその分解物を含有する歯周組織健康維持剤 | |
WO2005032542A1 (ja) | 空胞化毒素中和剤 | |
JP2005035909A (ja) | 抗歯周病剤 | |
JPH03284625A (ja) | 抗う蝕性物質の製造法及びその用途 | |
JP2005035908A (ja) | 抗歯周病剤 | |
JP2022103508A (ja) | SARS-CoV-2ウイルス感染抑制剤及びSARS-CoV-2ウイルス感染抑制用組成物 | |
JPH10215813A (ja) | 健康食品、口腔洗浄剤及び保健薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2005203558 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057014687 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2006165609 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10545412 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20058000528 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2005203558 Country of ref document: AU Date of ref document: 20050225 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005203558 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2520166 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005710716 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1020057014687 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10545412 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006511407 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005710716 Country of ref document: EP |